MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis.

ABSTRACT:

Background

MiR-193b has been widely investigated in the last few years and an aberrant association has been observed between its expression levels and the prognosis of several human malignancies. We performed a meta-analysis to evaluate the prognostic effect of miR-193b on human cancers.

Methods

PMC, PubMed, Web of Science (WOS), Embase in English and VIP, Wanfang, SinoMed and the China National Knowledge Infrastructure (CNKI) in Chinese were searched up to May 16, 2020. The pooled hazard ratio (HR) with a 95% confidence interval (CI) was calculated to evaluate its prognosis in human cancers. Also, the pooled odd ratios and the relevant 95% CIs were computed to assess the association of miR-193b levels and clinicopathological characteristics of cancer patients.

Results

SUBMITTER: Yu H 

PROVIDER: S-EPMC9372259 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature